Results 161 to 170 of about 908,966 (347)

Human Tumor Immunology and Molecular Biology from Basic Research to Clinical Application [PDF]

, 1993
Isabelle Tournier-Thurneyssen, Gérard Feldmann, Dominique Bernuau   +2 more
openalex   +1 more source

Corrigendum to "Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine" [Clinical Immunology 237 (2022) 108963]. [PDF]

Clin Immunol, 2023
Wong MK, Liu JT, Budylowksi P, Yue FY, Li Z, Rini JM, Carlyle JR, Zia A, Ostrowski M, Martin A.   +9 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Clinical Immunology. [PDF]

Archives of Internal Medicine, 1972
  +5 more sources

Editorial: Venoms and Toxins: At the Crossroads of Basic, Applied and Clinical Immunology. [PDF]

Front Immunol, 2021
Pucca MB, Fry BG, Sartim MA, Peigneur S, Monteiro WM.   +4 more
europepmc   +1 more source

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos, Marwa Al‐Dubai, Denise Walther, Dominic Borie, Jan D. Lünemann, Marc Pawlitzki, Sven G. Meuth, Solveig Henneicke, Stefan Vielhaber, Stefanie Schreiber   +9 more
wiley   +1 more source

Clinical immunology Proangiogenic factors in obese patients with type 1 diabetes [PDF]

, 2009
Karolina Rybarczyk-Kapturska, Katarzyna Zorena, Ewa Malinowska, Małgorzata Myśliwiec, Marcin Smardzewski, Jolanta Myśliwska   +5 more
openalex  

Immunology IV: Clinical Applications in Health and Disease by Joseph A. Bellanti [PDF]

, 2012
С. Бонини
openalex   +1 more source

AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper. [PDF]

Allergy, 2022
Bergmann C, Poli A, Agache I, Bianchini R, Bax HJ, Castells M, Crescioli S, Dombrowicz D, Ferastraoaru D, Fiebiger E, Gould HJ, Hartmann K, Izquierdo E, Jordakieva G, Josephs DH, Jutel M, Levi-Schaffer F, de Las Vecillas L, Lotze MT, Osborn G, Pascal M, Redegeld F, Rosenstreich D, Roth-Walter F, Schmidt-Weber C, Shamji M, Steveling EH, Turner MC, Untersmayr E, Jensen-Jarolim E, Karagiannis SN.   +30 more
europepmc   +1 more source

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuralgic amyotrophy (NA) is a prevalent, monophasic, multifocal immune‐mediated neuropathy. A distinctive characteristic of the disease is the occurrence of nerve or fascicle constrictions and torsions (NA‐associated focal nerve lesions, NAFL). The pathophysiology underlying this phenomenon remains to be fully elucidated.
Johannes Fabian Holle, Andreas Leha, Volker Limmroth, Wolfram Windisch, Maximilian Zimmermann   +4 more
wiley   +1 more source